Hepatitis C and insulin action: An intimate relationship

Area of Science:

• Hepatology
• Endocrinology
• Virology

Background:

• Chronic hepatitis C virus (HCV) infection is associated with a higher prevalence of type 2 diabetes.
• Diabetes is the most common extra-hepatic manifestation of HCV infection.
• HCV-associated diabetes stems from insulin resistance (IR), occurring early in the disease, even with minimal liver fibrosis.

Purpose of the Study:

• To elucidate the mechanisms of HCV-induced insulin resistance.
• To understand the impact of IR on HCV disease progression.
• To investigate the effect of IR on treatment response in HCV patients.

Main Methods:

• The study reviews existing literature on HCV, insulin resistance, and diabetes.
• It examines the molecular mechanisms underlying HCV-induced IR.
• It analyzes the clinical implications of IR in HCV progression and treatment.

Main Results:

• HCV directly interferes with insulin signaling pathways, causing IR.
• IR exacerbates hepatic fibrosis, cirrhosis, and hepatocellular carcinoma progression.
• IR may reduce the efficacy of traditional interferon/ribavirin therapy, but its effect on direct-acting antivirals is unknown.

Conclusions:

• HCV-induced IR is a key factor in the pathogenesis of diabetes in HCV patients.
• Managing IR is crucial for mitigating HCV-related liver disease progression.
• Further research is needed to determine IR's impact on novel direct-acting antiviral treatments.